• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

ElectroCore - Articles and news items

nvns

ElectroCore’s non-invasive vagus nerve (nVNS) stimulation therapy shown to be safe and to produce no meaningful cardiac adverse effects

Industry news / 28 April 2015 / Victoria White

Open-label trial shows electroCore’s nVNS therapy does not cause any meaningful cardiovascular adverse effects in patients with asthma…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +